The Future of CAR-T: Advancing Myeloma Treatment Strategies

Opinion
Video

Panelists discuss the evolving role of chimeric antigen receptor T-cell therapy in earlier lines of treatment for multiple myeloma, with a focus on upcoming advances for patients with standard-risk disease and the impact of multidisciplinary collaboration on improving patient care and outcomes.

Recent Videos
5 experts are featured in this series
4 experts in this video
2 experts are featured in this series.
4 experts in this video
4 experts in this video
4 experts in this video
2 experts are featured in this series.
5 experts are featured in this series
4 experts are featured in this series.
4 experts are featured in this series.
Related Content